Sunitinib for Taiwanese patients with gastrointestinal stromal tumor after imatinib treatment failure or intolerance

AIM: To report preliminary results of the efficacy and safety of sunitinib in the management of Taiwanese gastrointestinal stromal tumors (GIST) patients facing imatinib mesylate (IM) intolerance or failure. METHODS: Between 2001 and May 2010, 199 Taiwanese patients with metastatic GIST were treated...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Chen, Yen-Yang, Yeh, Chun-Nan, Cheng, Chi-Tung, Chen, Tsung-Wen, Rau, Kun-Ming, Jan, Yi-Yin, Chen, Miin-Fu
Format: Artigo
Idioma:Inglês
Publicat: Baishideng Publishing Group Co., Limited 2011
Matèries:
Brief Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3084397/
https://ncbi.nlm.nih.gov/pubmed/21547131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i16.2113
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars